deltatrials
Terminated PHASE4 INTERVENTIONAL 4-arm NCT01310738

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (LVBrasil)

Multicentric Efficacy and Safety Study of Antileishmanial Drugs for Treatment of Visceral Leishmaniasis in Brazil

Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conditions Visceral Leishmaniasis
Interventions Antimoniate of N-methylglucamine Liposomal amphotericin B amphotericin B deoxycholate
Updated 6 times since 2017 Last updated: Aug 31, 2017 Started: Feb 28, 2011 Primary completion: Oct 31, 2014 Completion: Feb 28, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

DSMB recommendation based on programmed interim analysis.

Other terminated trials from Conselho Nacional de Desenvolvimento Científico e Tecnológico

See all terminations from Conselho Nacional de Desenvolvimento Científico e Tecnológico

Other Visceral Leishmaniasis trials with similar outcome

Browse all Visceral Leishmaniasis trials

Listed as NCT01310738, this PHASE4 trial focuses on Visceral Leishmaniasis and remains terminated or withdrawn. Sponsored by Conselho Nacional de Desenvolvimento Científico e Tecnológico, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotTerminated~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Oct 2017 — Jun 2018 [monthly]

    Terminated PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Oct 2017 [monthly]

    Terminated PHASE4

    First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Drugs for Neglected Diseases
  • Ministry of Health, Brazil
  • University of Brasilia
Data source: University of Brasilia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations